4Indexed trials
drug · Product Intelligence
Galantamine
Pipeline Intelligence
Galantamine: 4 indexed trials, 4 sponsors; 0 linked Orange Book patents and 7 FDA-linked events where matched.
4Sponsors
0Orange Book patent links
7FDA-linked events
Development evidence
NCT00226824Parkinson's Disease and Movement Disorders Center · neurodevelopmental_otherPHASE4
NCT00301574Janssen Pharmaceutical K.K. · alzheimersPHASE3
NCT00320736North Suffolk Mental Health Association · schizophreniaPHASE4
NCT01734395Janssen Korea, Ltd., Korea · alzheimersCOMPLETED
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALGALANTAMINE HYDROBROMIDE · 2011-03-29
FDA_APPROVALGALANTAMINE HYDROBROMIDE · 2009-09-15
FDA_APPROVALGALANTAMINE HYDROBROMIDE · 2009-07-09
FDA_APPROVALGALANTAMINE HYDROBROMIDE · 2009-06-22
FDA_APPROVALGALANTAMINE HYDROBROMIDE · 2009-05-29
FDA_APPROVALGALANTAMINE HYDROBROMIDE · 2009-05-27
FDA_APPROVALGALANTAMINE HYDROBROMIDE · 2008-09-11
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.